摘要:
The invention concerns a nucleic material, in isolated or purified state, and a nucleotide fragment comprising a nucleotide sequence selected from the group consisting in (i) the sequences SEQ ID NO: 112, SEQ ID NO:114, SEQ ID NO: 117, SEQ ID NO: 120, SEQ ID NO. 124, SEQ ID NO: 130, SEQ ID NO: 141 and SEQ ID NO: 142, (ii) the complementary sequences of sequences (i); and (iii) the sequences equivalent to sequences (ii) and (iii), in particular the sequence having for every series of 100 contiguous monomers, at least 50%, preferably 70% homology with sequences (i) and (ii) respectively. The invention also concerns their uses for detecting a retrovirus associated with multiple sclerosis and/or rheumatoid arthritis.
摘要翻译:本发明涉及分离或纯化状态的核酸,以及包含选自(i)序列SEQ ID NO:112,SEQ ID NO:114,SEQ ID NO:117, SEQ ID NO:120,SEQ ID NO: 124,SEQ ID NO:130,SEQ ID NO:141和SEQ ID NO:142,(ii)序列(i)的互补序列; 和(iii)与序列(ii)和(iii)相当的序列,特别是具有每100个连续单体的序列的序列,分别与序列(i)和(ii)具有至少50%,优选70%的同源性。 本发明还涉及其用于检测与多发性硬化和/或类风湿性关节炎相关的逆转录病毒的用途。
摘要:
An isolated polynucleotide having a nucleotide sequence selected from the group consisting of (a) SEQ ID NO: 21, (b) the full-length sequences encoding a polypeptide having a peptide sequence selected from the group consisting of SEQ ID NOs: 25 and 26, and (c) the full-length complementary sequences to the sequences set forth in (a) or (b).
摘要翻译:一种分离的多核苷酸,其具有选自(a)SEQ ID NO:21,(b)编码具有选自SEQ ID NO:25和26的肽序列的多肽的全长序列的核苷酸序列 ,和(c)与(a)或(b)中列出的序列的全长互补序列。
摘要:
An isolated polynucleotide having a nucleotide sequence selected from the group consisting of (a) SEQ ID NO: 21, (b) the full-length sequences encoding a polypeptide having a peptide sequence selected from the group consisting of SEQ ID NOs: 25 and 26, and (c) the full-length complementary sequences to the sequences set forth in (a) or (b).
摘要翻译:一种分离的多核苷酸,其具有选自(a)SEQ ID NO:21,(b)编码具有选自SEQ ID NO:25和26的肽序列的多肽的全长序列的核苷酸序列 ,和(c)与(a)或(b)中列出的序列的全长互补序列。
摘要:
The invention provides viral material and nucleotide fragments associated with multiple sclerosis and/or rheumatoid arthritis for use in method of diagnosis, prophylaxis, and therapy.
摘要:
Viral material, in the isolated or purified state, in which the genome comprises a nucleotide sequence chosen from the group including sequences SEQ ID NO:46, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:56, their complementary sequences and their equivalent sequences, in particular nucleotide sequences displaying, for any succession of 100 contiguous monomers, at least 50% and preferably at least 70% homology with the said sequences SEQ ID NO:46, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:56, respectively, and their complementary sequences.
摘要翻译:分离或纯化状态的病毒物质,其中基因组包含选自SEQ ID NO:46,SEQ ID NO:51,SEQ ID NO:52,SEQ ID NO:53和SEQ ID NO:53的核苷酸序列 SEQ ID NO:46,SEQ ID NO:56,其互补序列及其等同序列,特别是核苷酸序列,显示100个连续单体的任何连续序列,与所述序列SEQ ID NO:46,SEQ ID NO为至少50%,优选至少70% :51,SEQ ID NO:52,SEQ ID NO:53和SEQ ID NO:56及其互补序列。
摘要:
The invention provides viral material and nucleotide fragments associated with multiple sclerosis and/or rheumatoid arthritis for use in methods of diagnosis, prophylaxis, and therapy.
摘要:
Viral material, in the isolated or purified state, in which the genome comprises a nucleotide sequence chosen from the group including sequences SEQ ID NO:46, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:56, their complementary sequences and their equivalent sequences, in particular nucleotide sequences displaying, for any succession of 100 contiguous monomers, at least 50% and preferably at least 70% homology with the said sequences SEQ ID NO:46, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:56, respectively, and their complementary sequences.
摘要翻译:分离或纯化状态的病毒物质,其中基因组包含选自SEQ ID NO:46,SEQ ID NO:51,SEQ ID NO:52,SEQ ID NO:53和SEQ ID NO:53的核苷酸序列 SEQ ID NO:46,SEQ ID NO:56,其互补序列及其等同序列,特别是核苷酸序列,显示100个连续单体的任何连续序列,与所述序列SEQ ID NO:46,SEQ ID NO为至少50%,优选至少70% :51,SEQ ID NO:52,SEQ ID NO:53和SEQ ID NO:56及其互补序列。
摘要:
The invention provides viral material and nucleotide fragments associated with multiple sclerosis and/or rheumatoid arthritis for use in method of diagnosis, prophylaxis, and therapy.
摘要:
Viral material, in the isolated or purified state, in which the genome comprises a nucleotide sequence chosen from the group including sequences SEQ ID NO:46, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:56, their complementary sequences and their equivalent sequences, in particular nucleotide sequences displaying, for any succession of 100 contiguous monomers, at least 50% and preferably at least 70% homology with the said sequences SEQ ID NO:46, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:56, respectively, and their complementary sequences.
摘要翻译:分离或纯化状态的病毒物质,其中基因组包含选自SEQ ID NO:46,SEQ ID NO:51,SEQ ID NO:52,SEQ ID NO:53和SEQ ID NO:53的核苷酸序列 SEQ ID NO:46,SEQ ID NO:56,其互补序列及其等同序列,特别是核苷酸序列,显示100个连续单体的任何连续序列,与所述序列SEQ ID NO:46,SEQ ID NO为至少50%,优选至少70% :51,SEQ ID NO:52,SEQ ID NO:53和SEQ ID NO:56及其互补序列。
摘要:
The invention relates to: a nucleotide fragment of an MSRV-1 LTR-RU5 region, comprising a nucleotide sequence encoding the expression of a protein, wherein the protein comprises a peptide sequence selected from the group consisting of: SEQ ID NO: 2, SEQ ID NO: 3, and SEQ ID NO: 4; complementary nucleotide fragments; probes and primers that hybridize to the fragment; proteins encoded by the fragment; antibodies directed against the proteins encoded by the fragment; and processes for detecting the presence of MSRV-1 using a probe or an antibody of the invention.
摘要翻译:本发明涉及:MSRV-1LTR-RU5区域的核苷酸片段,其包含编码蛋白质表达的核苷酸序列,其中所述蛋白质包含选自下组的肽序列:SEQ ID NO:2,SEQ ID NO: SEQ ID NO:3和SEQ ID NO:4; 互补核苷酸片段; 与片段杂交的探针和引物; 由片段编码的蛋白质; 针对由片段编码的蛋白质的抗体; 以及使用本发明的探针或抗体检测MSRV-1的存在的方法。